Hydrofarm Holdings Group Inc.

11/16/2026 | Press release | Distributed by Public on 11/16/2026 15:49

Quarterly Report for Quarter Ending September 30, 2026 (Form 10-Q)

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provides information that we believe is relevant to an assessment and understanding of our results of operations and financial condition. You should read this analysis in conjunction with our audited and unaudited condensed consolidated financial statements and the notes contained elsewhere in this Quarterly Report on Form 10-Q and our 2025 Annual Report. This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance. Actual events or results may differ materially from forward-looking statements. In evaluating such statements, you should carefully consider the various factors identified in this Quarterly Report on Form 10-Q, which could cause actual results to differ materially from those expressed in, or implied by, any forward-looking statements, including those set forth in Item 1A. "Risk Factors" in our 2025 Annual Report. See "Special Note Regarding Forward-Looking Statements."

Company Overview

We are a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative, proprietary branded products. We primarily serve the U.S. and Canadian markets, and believe we are one of the leading companies in these markets in an otherwise fragmented industry. For nearly 50 years, we have helped growers make growing easier and more productive. Our mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency, and speed in their grow projects.

Hydroponics is the farming of plants using soilless grow media and often artificial lighting in a controlled indoor or greenhouse environment. Hydroponics is the primary category of CEA and we use the terms CEA and hydroponics interchangeably. Our products are used to grow, farm, and cultivate cannabis, flowers, fruits, plants, vegetables, grains, and herbs in controlled environment settings that allow end users to control key farming variables including temperature, humidity, CO2, light intensity spectrum, nutrient concentration and pH. Through CEA, growers are able to be more efficient with physical space, water and resources, while enjoying year-round and more rapid grow cycles as well as more predictable and abundant grow yields, when compared to other traditional growing methods.

We reach commercial farmers and consumers through a broad and diversified network, who we connect with primarily through our proprietary online ordering platform. Our products are distributed across the United States and Canada through a diversified range of retailers of commercial and home gardening equipment and supplies. Our customers include specialty hydroponic retailers, commercial resellers and greenhouse builders, garden centers, hardware stores, and e-commerce retailers. Specialty hydroponic retailers can provide growers with specialized merchandise assortments and knowledgeable staff. Our logistics services business manages the receipt, warehousing, and distribution of multiple customer accounts, leveraging our warehouse space in multiple distribution centers in the U.S. and Canada. These logistics agreements and operating subleases are accounted for as an offset and reduction to facility expense within SG&A.

Recent Developments

On October 27, 2026, we entered into a securities purchase agreement with certain institutional investors for the purchase of 1,599,400 Registered Shares of common stock in the Registered Direct Offering at a purchase price of $0.905. In the Private Placement, investors also agreed to purchase 6,971,575 Unregistered Shares of common stock, Pre-Funded Warrants to purchase up to 640,000 shares of common stock at a purchase price of $0.9049 per share of common stock and an exercise price of $0.0001 per Pre-Funded Warrant and Common Warrants to purchase up to a number of shares of common stock equal to 100% of such investor's Registered Shares, Unregistered Shares and/or Pre-Funded Warrants, being an aggregate of 9,210,975 shares of common stock, at an exercise price of $0.78 per share. The Pre-Funded Warrants are immediately exercisable and may be exercised at a nominal consideration of $0.0001 per share of common stock at any time until all of the Pre-Funded Warrants are exercised in full. The Common Warrants are immediately exercisable and expire 5.5 years following the issue date. Holders of the Warrants will not have the right to exercise any portion of the Warrants if the holder (together with certain of its affiliates) would beneficially own in excess of 4.99% (or, upon election of the holder, 9.99%) of the number of shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants. Total gross proceeds from the Offering, before deducting the Placement Agent fee and offering expenses were approximately $8.3 million. We intend to use the proceeds from the Offering for general corporate purposes.

Concurrently with the closing of the Offering, on October 27, 2026, we satisfied our obligations under the Term Loan pursuant to the terms of a payoff letter with the former Term Loan lenders. Such payoff letter required that we deliver to the former Term Loan lenders, in the aggregate, (i) 27.5 million shares of Series 1 Non-Voting Convertible Preferred Stock and (ii) Lender Warrants to purchase 27.5 million shares of common stock at an exercise price equal to $0.78. Each share of Series 1 Non-Voting Convertible Preferred Stock has a par value of $0.0001 per share and a stated value equal to $1.00. The Series 1 Non-Voting Convertible Preferred Stock ranks (i) senior to the common stock and any other class or series of our capital stock thereafter created, the terms of which specifically provide that such class or series shall rank junior to the Series 1 Non-Voting Convertible Preferred Stock, and (ii) pari passu with any class or series of our capital stock created specifically ranking, by its terms, on par with the Series 1 Non-Voting Convertible Preferred Stock. The Series 1 Non-Voting Convertible Preferred Stock shall be convertible into 27.5 million shares of common stock, determined by dividing the Stated Value per share of Series 1 Non-Voting Convertible Preferred Stock by the per share conversion price (as adjusted from time to time) and the Lender Warrants shall be exercisable, commencing upon receipt of any required stockholder approvals, and shall in all cases be subject to a 4.99% beneficial ownership limitation. We also entered into a side letter agreement, which provides for, among other things, the right of certain lenders to designate one director to our board of directors and following, and subject to, approval by our stockholders under the Nasdaq Stock Market, or Nasdaq, listing rules or confirmation by Nasdaq, that such appointments do not violate its rules, the lenders shall have the right to designate up to three additional directors to our board of directors.

As a result of the consummation of the Offering and the Term Loan Settlement, we regained compliance with the Equity Rule as confirmed by Nasdaq on November 9, 2026.

For additional information, see Item 1. Financial Statements, Note 2 - Liquidity and Going Concern and Note 17 - Subsequent Events to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q and " - Liquidity and Capital Resources - Availability and Use of Cash."

Market Conditions and Restructuring Plans

We have experienced adverse financial results which we believe are primarily a result of an agricultural oversupply impacting our market and resulting in a decrease in indoor and outdoor cultivation. The extent to which these market conditions will continue to negatively impact our business and results of operations is uncertain and difficult to predict at this time. We believe COVID-19 may have provided a positive demand impact for the Company in 2020 and 2021 from shelter-in-place orders in the United States, a possible negative supply chain impact from workforce disruption at international and domestic suppliers, and a possible negative growth rate impact in the periods since, due to agricultural oversupply initiated during the height of COVID-related shelter-in-place orders in 2020 and 2021. In addition, we believe demand for our products has been negatively impacted by the extended period to enact reform of U.S. federal regulations, including cannabis rescheduling, which have been slow to develop and possibly leading cannabis operators to reduce investments in our products, particularly durable goods. In addition, we believe our financial results have been negatively impacted by hydroponic retail store closings and, in some cases, associated accounts receivable allowances.

During the fourth quarter of fiscal 2025, as a result of industry conditions, primarily attributable to an agricultural oversupply impacting our market and resulting in a decrease in indoor and outdoor cultivation, as well as continued declines in operating cash flows and profitability, we assessed our long-lived assets for impairment and recorded an impairment charge of $232.2 million. Of such impairment charge, $228.4 million was related to finite-lived intangible assets and $3.8 million was related to property, plant, and equipment. The loss was recorded in Impairments in the consolidated statement of operations for the year ended December 31, 2025. We estimated fair value based on the income approach and market approach. Under the income approach, we estimated the fair value of the asset group on the present value of estimated future cash flows, which we considered to be a level 3 unobservable input in the fair value hierarchy.

During the second quarter of 2025, we initiated the 2025 Restructuring Plan to reduce our product portfolio and operational footprint to decrease costs and improve efficiency. The 2025 Restructuring Plan actions entailed (i) eliminating a significant portion of our product portfolio, primarily underperforming distributed brands, to improve supply chain and operational focus, (ii) further reductions in our distribution center network and manufacturing footprint, and (iii) corresponding headcount reductions. Since the 2025 Restructuring Plan's inception, we have incurred estimated restructuring costs of $12.0 million. The charges were primarily associated with non-cash inventory write-downs, which were recorded in cost of goods sold on the condensed consolidated statements of operations, and cash and non-cash charges which primarily comprised of charges incurred to relocate and terminate certain facilities. We do not anticipate the 2025 Restructuring Plan and related actions will result in additional material restructuring charges, and anticipate annual cost savings of over $5 million plus additional working capital benefits. The 2025 Restructuring Plan is expected to be completed during 2026.

On April 30, 2026, we completed the closing of the previously announced agreement with Quality Horticulture, a family-owned Canadian garden center and horticultural distribution company, pursuant to which Quality Horticulture will serve as the exclusive Canadian distributor of our proprietary portfolio of nutrients, plant additives, grow media, horticultural lighting and environmental control products, including House & Garden, Grotek, Gaia Green, PHOTOBIO, SunBlaster and Active Aqua. As a result of the transaction, Hydrofarm no longer distributes third- party branded products in Canada. The transaction is part of our strategic plan to streamline our operations and improve the focus on our proprietary brands and core product categories.

On July 31, 2026, we completed the APP Sale for total consideration of $16 million, including a $5 million secured promissory note, which was assigned to the former Term Loan lenders, subject to adjustments set forth in the Share Purchase Agreement. The net proceeds were applied to reduce outstanding debt, including outstanding interest, under the Term Loan. The transaction is part of our strategic plan to streamline our operations and improve the focus on our proprietary brands and core product categories.

We continue to evaluate our product portfolio and supply chain, in order to improve efficiency, lower our costs and reduce footprint. We are also evaluating other opportunities to sell excess owned land, not currently being used in operations, to supplement our cash position and potential contract manufacturing or other outsourcing arrangements. Depending on the length and severity of the industry and market conditions, including the fluid and complex international tariff and trade policies, impacting our business, our ability to successfully negotiate with key vendors, and the pursuit of additional financing or strategic alternatives, it is possible we may execute additional restructuring plan actions and incur future associated charges, and we may not be able to realize the full extent of our anticipated cost savings.

Additionally, the amount we will ultimately realize as benefits associated with our restructuring plans could differ materially from our estimates, and we may incur additional non-cash charges in future periods depending on our ability to execute asset sales or pursue other alternatives. For additional information, see the Item 1A. "Risk Factors" in our 2025 Annual Report, including the risk entitled "Our restructuring activities may increase our expenses and cash expenditures, and may not have the intended effects."

We maintain an allowance for excess and obsolete inventory that is based upon assumptions about future demand and market conditions. While we believe our estimates of charges relating to our 2025 Restructuring Plan, long-lived assets, inventory obsolescence, and accounts receivable allowances are reasonable, it is possible that we may incur additional charges in the future and actual results may differ significantly from these estimates and assumptions.

We are closely monitoring the recent tariff and trade policy actions taken by the United States and foreign governments. The situation remains fluid due to the rapidly changing global trade environment, and we continue to evaluate the potential implications of these actions on our business including net sales and profitability. High tariffs on imported products from China or other countries, or new tariffs from other countries, have impacted and could impact the cost of certain products and may negatively impact our financial performance. We have been able to help mitigate the impacts of tariffs through filing for refunds to the extent available to us, negotiations with vendors, and through passing nominal price increases to our customers, but we may be unable to quickly and effectively react to additional tariff and trade policy actions which may impact our business.

Results of Operations-Comparison of three and nine months ended September 30, 2026 and 2025

The following table sets forth our unaudited interim condensed consolidated statements of operations for the three and nine months ended September 30, 2026, and 2025, including amounts and percentages of net sales for each period and the period-to-period change in dollars and percent (amounts in thousands):

Three months ended September 30,

2026

2025

Period change

Net sales

$

14,455

100.0

%

$

29,350

100.0

%

$

(14,895

)

-50.7

%

Cost of goods sold

11,897

82.3

%

25,941

88.4

%

(14,044

)

-54.1

%

Gross profit

2,558

17.7

%

3,409

11.6

%

(851

)

-25.0

%

Operating expenses:

Selling, general and administrative

7,955

55.0

%

16,365

55.8

%

(8,410

)

-51.4

%

Gain on sale of business

(1,491

)

-10.3

%

-

0.0

%

(1,491

)

N/A

Loss from operations

(3,906

)

-27.0

%

(12,956

)

-44.1

%

9,050

69.9

%

Interest expense

(3,385

)

-23.4

%

(3,331

)

-11.3

%

(54

)

-1.6

%

Other (expense) income, net

(367)

-2.5

%

22

0.1

%

(389

)

-1,768.2

%

Loss before tax

(7,658

)

-53.0

%

(16,265

)

-55.4

%

8,607

52.9

%

Income tax expense

(121

)

-0.8

%

(125

)

-0.4

%

4

3.2

%

Net loss

$

(7,779

)

-53.8

%

$

(16,390

)

-55.8

%

$

8,611

52.5

%

Nine months ended September 30,

​

​

2026

2025

Period change

Net sales

$

66,190

100.0

%

$

109,129

100.0

%

$

(42,939

)

-39.3

%

Cost of goods sold

59,161

89.4

%

96,049

88.0

%

(36,888

)

-38.4

%

Gross profit

7,029

10.6

%

13,080

12.0

%

(6,051

)

-46.3

%

Operating expenses:

​

​

​

​

​

​

Selling, general and administrative

28,585

43.2

%

50,368

46.2

%

(21,783

)

-43.2

%

Gain on sale of business

(1,491

)

-2.3

%

-

0.0

%

(1,491

)

N/A

Loss from operations

(20,065

)

-30.3

%

(37,288

)

-34.2

%

17,223

46.2

%

Interest expense

(12,704

)

-19.2

%

(10,099

)

-9.3

%

(2,605

)

-25.8

%

Other expense, net

(464

)

-0.7

%

(140

)

-0.1

%

(324

)

-231.4

%

Loss before tax

(33,233

)

-50.2

%

(47,527

)

-43.6

%

14,294

30.1

%

Income tax benefit (expense)

212

0.3

%

(109

)

-0.1

%

321

294.5

%

Net loss

$

(33,021

)

-49.9

%

$

(47,636

)

-43.7

%

$

14,615

30.7

%

Net sales

Net sales for the three months ended September 30, 2026, were $14.5 million, a decrease of $14.9 million, or 50.7% compared to the same period in 2025. Net sales for the nine months ended September 30, 2026, were $66.2 million, a decrease of $42.9 million, or 39.3% compared to the same period in 2025.

The 50.7% decrease in net sales for the three months ended September 30, 2026, as compared to the same period in 2025, was primarily due to a 50.9% reduction in volume and mix of products sold, as price and foreign currency had a minimal net impact. This decline was largely driven by the discontinuation of certain distributed brands, exiting from the distribution business in Canada and the APP Sale. The decrease in net sales for the three months ended September 30, 2026, as compared to the same period in 2025, was $3.7 million from exiting the distribution business in Canada and $1.3 million from the APP Sale. The 39.3% decrease in net sales for the nine months ended September 30, 2026, as compared to the same period in 2025, was primarily due to a 37.0% reduction in volume and mix of products sold and a 2.7% decrease in price. This decline was largely driven by the discontinuation of certain distributed brands, the aforementioned business divestitures in Canada, and the previously mentioned industry oversupply. The decrease in net sales for the nine months ended September 30, 2026, as compared to the same period in 2025, was $5.4 million from exiting the distribution business in Canada and $1.3 million from the APP Sale.

Gross profit

Gross profit for the three months ended September 30, 2026, was $2.6 million, a decrease of $0.9 million, or 25.0%, compared to the same period in 2025. Our gross profit margin percentage increased to 17.7% for the three months ended September 30, 2026, from 11.6% in the same period in 2025. The increase in gross profit margin for the three months ended September 30, 2026 was largely driven by selling a higher proportion of proprietary brand products and a $0.7 million decrease in restructuring charges from the prior year period, partially offset by lower manufacturing production volumes in certain grow media products and higher labor and freight costs as a percentage of net sales.

Gross profit for the nine months ended September 30, 2026, was $7.0 million, a decrease of $6.1 million, or 46.3%, compared to the same period in 2025. Our gross profit margin percentage decreased to 10.6% for the nine months ended September 30, 2026, from 12.0% in the same period in 2025. Our gross profit margin percentage for the nine months ended September 30, 2026 decreased primarily due to higher freight and labor costs as a percentage of net sales and lower manufacturing production volumes in certain grow media products, which more than offset a $1.6 million decrease in restructuring charges from the prior year period and the benefit from selling a higher proportion of proprietary brand products.

The decreases in gross profit for all periods presented were primarily due to the aforementioned lower net sales.

Selling, general and administrative expenses

SG&A expenses for the three months ended September 30, 2026, were $8.0 million, a decrease of $8.4 million, or 51.4% compared to the same period in 2025. SG&A expenses decreased in several areas, including as a result of our cost-saving and restructuring initiatives: (i) a $6.0 million decrease in amortization and depreciation primarily due to intangible asset impairments in 2025, (ii) a $1.7 million decrease in employee compensation costs, including lower salaries and benefits, stock-based compensation, and performance bonus, and (iii) a $1.3 million decrease in facility expenses, partially offset by increases in other expenses including professional fees from the Company's debt transactions and strategic alternatives process.

SG&A expenses for the nine months ended September 30, 2026, were $28.6 million, a decrease of $21.8 million, or 43.2% compared to the same period in 2025. SG&A expenses decreased in several areas, including as a result of our cost-saving and restructuring initiatives: (i) a $17.9 million decrease in amortization and depreciation primarily due to intangible asset impairments in 2025, (ii) a $4.0 million decrease in employee compensation costs, including lower salaries and benefits, stock-based compensation, and performance bonus, and (iii) a $3.0 million decrease in facility expenses, partially offset by increases in other expenses including professional fees from the Company's debt transactions and strategic alternatives process.

Gain on sale of business

On July 31, 2026, we completed the APP Sale. We recognized a gain on sale of business of $1.5 million for the three and nine months ended September 30, 2026. Upon the closing of the sale transaction, the then outstanding amounts in Accumulated other comprehensive loss were reclassified to net income through gain on sale of business for a total of $2.2 million.

Interest expense

Interest expense for the three months ended September 30, 2026, was $3.4 million, an increase from $3.3 million of interest expense recorded in the same period in the prior year. Interest expense for the nine months ended September 30, 2026, was $12.7 million, an increase from $10.1 million of interest expense recorded in the same period in the prior year. The increase for the nine months ended September 30, 2026, was primarily due to the acceleration of our Term Loan discount and deferred financing costs triggered by the Specified Event of Default.

Other income (expense), net

Other expense, net for the three months ended September 30, 2026, was $0.4 million, compared to other income, net of less than $0.1 million during the same period in the prior year. Other expense, net for the nine months ended September 30, 2026, was $0.5 million, compared to other expense, net of $0.1 million during the same period in the prior year.

Income taxes

We recorded income tax expense of $0.1 million for the three months ended September 30, 2026, and an income tax benefit of $0.2 million for the nine months ended September 30, 2026, representing effective tax rates of (1.6)% and 0.6%, respectively. Our effective tax rates for the three and nine months ended September 30, 2026, differ from the federal statutory rate of 21% primarily due to U.S. and foreign jurisdictions in full valuation allowance. The income tax expense for the three months ended September 30, 2026, was primarily due to foreign taxes in Canada, and the income tax benefit for the nine months ended September 30, 2026, was primarily due to certain benefits in Canadian jurisdictions, partially offset by U.S. state taxes.

We recorded income tax expense of $0.1 million for the three and nine months ended September 30, 2025, representing effective tax rates of (0.8)% and (0.2)%, respectively. Our effective tax rates for the three and nine months ended September 30, 2025, differ from the federal statutory rate of 21% primarily due to U.S. and foreign jurisdictions in full valuation allowance. The income tax expense for the three and nine months ended September 30, 2025, was primarily due to foreign taxes in certain jurisdictions and U.S. state taxes, partially offset by certain benefits in Canadian jurisdictions.

Liquidity and Capital Resources

Cash Flow from Operating, Investing, and Financing Activities

Comparison of the nine months ended September 30, 2026, and September 30, 2025

The following table summarizes our cash flows for the nine months ended September 30, 2026, and 2025 (amounts in thousands):

Nine months ended September 30,

2026

2025

Net cash used in operating activities

$

(8,193)

$

(10,084

)

Net cash from (used in) investing activities

11,687

(608

)

Net cash used in financing activities

(5,902)

(5,242

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(20)

475

Net decrease in cash, cash equivalents and restricted cash

(2,428)

(15,459

)

Cash, cash equivalents and restricted cash at beginning of period

6,309

26,111

Cash, cash equivalents and restricted cash at end of period

$

3,881

$

10,652

Operating Activities

Net cash used in operating activities was $8.2 million for the nine months ended September 30, 2026. The net cash usage was primarily due to a $33.0 million net loss, partially offset by net non-cash items of $16.0 million and an $8.8 million net cash inflow from a decrease in working capital. The $8.8 million net decrease in working capital was primarily comprised of a $10.2 million decrease of inventories, a $3.0 million increase in accrued expenses and other current liabilities, a $1.4 million decrease in prepaid expenses and other current assets, and a $1.1 million increase of accounts payable, partially offset by a $5.4 million decrease of lease liabilities and a $2.0 million decrease in deferred revenue. The increase in accrued expenses and other current liabilities was primarily attributable to legal and advisory services associated with the APP Sale and the debt transactions. The Company is continuing to consolidate its operations in connection with restructuring and related cost saving initiatives which has contributed to the aforementioned decrease in inventory. During the nine months ended September 30, 2026, we paid $4.7 million in cash interest and settled $5.0 million of interest payable through an assignment, to the former Term Loan lenders, of the promissory note representing a deferred portion of the APP Sale purchase price.

Net cash used in operating activities was $10.1 million for the nine months ended September 30, 2025. The net cash usage was primarily due to a $47.6 million net loss, partially offset by net non-cash items of $35.6 million and a $2.0 million net cash inflow from a decrease in working capital. The $2.0 million net decrease in working capital was primarily comprised of a $5.7 million decrease of lease liabilities, a $3.1 million decrease in accrued expenses and other current liabilities, partially offset by a $7.7 million decrease in inventory. During the nine months ended September 30, 2025, we paid $9.5 million in cash interest.

Investing Activities

Net cash from investing activities was $11.7 million for the nine months ended September 30, 2026, compared to net cash used in investing activities of $0.6 million for the nine months ended September 30, 2025. The net cash from investing activities for the nine months ended September 30, 2026 was primarily due to proceeds from the APP Sale of $10.3 million and $1.5 million from the sale of property, plant and equipment. We did not have any significant capital expenditures of property, plant and equipment during the nine months ended September 30, 2026. The net cash used in investing activities for the nine months ended September 30, 2025 was primarily due to capital expenditures of property, plant and equipment.

Financing Activities

Net cash used in financing activities was $5.9 million for the nine months ended September 30, 2026, primarily driven by (i) $5.5 million of Term Loan repayments made in conjunction with the APP Sale, and (ii) finance lease principal payments of $0.3 million.

Net cash used in financing activities was $5.2 million for the nine months ended September 30, 2025, primarily driven by (i) $4.9 million of Term Loan repayments relating to required quarterly payments of principal and payments made in conjunction with the reinvestment provision as applied to the sale of assets relating to the production of Innovative Growers Equipment ("IGE") durable equipment products in May 2024, and (ii) finance lease principal payments of $0.3 million.

Availability and Use of Cash

As of September 30, 2026, we had $3.9 million in cash, cash equivalents and restricted cash and a working capital deficit of $105.4 million, which included $108.9 million of Term Loan principal classified as current due to the event of default. On October 27, 2026, the Term Loan was satisfied in full in connection with the Term Loan Settlement, and we received gross proceeds of approximately $8.3 million from the Offering.

We have incurred recurring operating losses and negative cash flows from operations and have other current liabilities, some of which are in active negotiation with vendors. As of September 30, 2026, we had $3.9 million in cash, cash equivalents and restricted cash and a working capital deficit of $105.4 million. These conditions and events, considered in the aggregate, raise substantial doubt about our ability to continue as a going concern. Our plans to address these conditions include reducing costs through restructuring and other initiatives, including facility consolidations, headcount reductions, focusing on our proprietary brand offerings, and expanding and optimizing our logistics business. In addition, we may seek additional funds through various financing sources, including the sale of equity securities or other debt financing.

Although we have made progress towards our plans, the ultimate outcome of our plans to address our condition are not within our control, and therefore cannot be deemed probable. As a result, we have concluded that management's plans do not alleviate substantial doubt about our ability to continue as a going concern.

During the second quarter of 2026, we sold approximately 38 acres of the 120 acres of excess owned land at the Goshen, New York location for $1.4 million.

On July 31, 2026, we completed the APP Sale for $16 million, subject to adjustments set forth in the Share Purchase Agreement. In connection with the APP Sale, the Buyer issued to us a promissory note in the principal amount of $5 million, representing a deferred portion of the purchase price. The net proceeds from the APP Sale, inclusive of the promissory note, were applied to reduce outstanding debt, including outstanding interest, under the Term Loan. Cash obligations in connection with the close of the APP Sale were $2.7 million. We recognized a gain on sale of business of approximately $1.5 million from the APP Sale.

Term Loan

On October 25, 2021, we and certain of our direct and indirect subsidiaries entered into the Term Loan with JPMorgan Chase Bank, N.A., as administrative agent for the lenders, pursuant to which we borrowed a $125 million senior secured term loan. The Term Loan was amended by Amendment No. 1 effective as of June 27, 2023, to replace the LIBOR referenced rates with SOFR referenced rates. Pursuant to Amendment No. 1, any Term Loan that constitutes a Eurodollar Rate Loan that is outstanding as of the Amendment No. 1 closing date shall continue until the end of the applicable interest period for such Eurodollar Rate Loan and the provisions of the Term Loan applicable thereto shall continue and remain in effect (notwithstanding the occurrence of the Amendment No. 1 closing date) until the end of the applicable interest period for such Eurodollar Rate Loan, after which such provisions shall have had no further force or effect. Such Eurodollar Rate Loan shall subsequently either be an ABR Loan or a Term Benchmark Loan. The ABR Loans shall bear interest at the Alternate Base Rate (with a 2.0% floor) plus 4.50%, and Term Benchmark Loans shall bear interest at the Adjusted Term SOFR Rate (with a 1.0% floor) plus 5.50%. As of the date of filing the 2025 Annual Report, the ABR Loan and Term Benchmark Loan credit spreads of 4.50% and 5.50%, respectively, within the Amendment No. 1 had not changed from the credit spreads in the original Term Loan. On April 8, 2026, we, the Lenders and the Agents entered into Amendment No. 2 to the Credit and Guaranty Agreement. Amendment No. 2 amends the Term Loan to, among other things, (i) replace JPMorgan with FEAC as the administrative agents; and (ii) require each credit party to covenant and agree to (A) regularly provide certain liquidity reports and cash flow forecasts, (B) regularly provide certain aging reports and inventory reports, and (C) maintain a minimum liquidity of $1 million.

The Term Loan matures on October 25, 2028, and is secured by a first lien on our non-working capital assets and a second lien on our working capital assets.

The principal amounts of the Term Loan are scheduled to be repaid in consecutive quarterly installments in amounts equal to 0.25% of the original principal amount of the Term Loan on the last day of each fiscal quarter commencing March 31, 2022, with the balance of the Term Loan payable on the Maturity Date. We are also required to make mandatory prepayments in the event of (i) achieving certain excess cash flow criteria, including the achievement and maintenance of a specific leverage ratio, (ii) certain asset sales that are collateral, or (iii) upon the issuance, offering, or placement of new debt obligations. In accordance with this provision, we made prepayments of $4.6 million during 2025 for an asset sale completed in 2024. The prepayments reduced our required quarterly installment amounts to zero for the remaining term.

The Term Loan requires us to maintain certain reporting requirements, affirmative covenants, and negative covenants. On February 4, 2026, we elected to defer making an interest payment of approximately $2.8 million on the Term Loan. As a result of our failure to pay the interest within the grace period, an event of default occurred with respect to the Term Loan. On February 11, 2026, the lenders, through the administrative agent, notified us of the Specified Event of Default and informed us that the administrative agent or the collateral agent may exercise any rights and remedies provided under the Term Loan agreement and related financing documents, but it did not seek to enforce such remedies as of such time.

On the Forbearance Effective Date, the Company entered into the Forbearance Agreement with the other Obligors, the Lenders, and FEAC, in connection with the Term Loan. Pursuant to the Forbearance Agreement, during the Forbearance Period (as defined in Note 11 - Debt to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q), solely with respect to the Specified Event of Default, neither the Administrative Agent nor any Lender shall, upon the terms and conditions expressly specified therein, take any action, commence any proceedings against any Obligor or any other person with respect to the enforcement of any of its or their rights or remedies under the Credit Documents or applicable law, other than as expressly described in the Forbearance Agreement. The Company, the Lenders, and FEAC agreed to extend the Forbearance Period under the Forbearance Agreement through and including August 31, 2026. As of September 30, 2026, the Forbearance Period had lapsed and the Forbearance Agreement was no longer in effect, however neither the Administrative Agent nor any Lender has taken any action, commenced any proceedings against any Obligor or any other person with respect to the enforcement of any of its or their rights or remedies under the Credit Documents or applicable law.

On October 27, 2026, the Company entered into a securities purchase agreement with certain institutional investors for the purchase of 1,599,400 shares of common stock in a registered direct offering at a purchase price of $0.905 priced at-the-market under Nasdaq rules. In a concurrent private placement, investors also agreed to purchase 7,611,575 unregistered shares of common stock (or Pre-funded Warrants in lieu thereof) and 9,210,975 Common Warrants at a purchase price of $0.9050. Each Common Warrant is exercisable for one share of common stock at an exercise price of $0.78 and will expire five and a half years from the issuance date. Total gross proceeds from the offering, before deducting the placement agent fee and offering expenses were approximately $8.3 million. All of the shares of common stock, Pre-funded Warrants, and Common Warrants are being sold by the Company.

Concurrently with the closing of the Registered Direct Offering and the Private Placement on October 27, 2026, the Company satisfied its obligations under the senior secured Term Loan pursuant to the terms of a payoff letter with the lenders. Such payoff letter required that the Company deliver to the lenders, in the aggregate, (i) 27.5 million shares of Series 1 Non-Voting Convertible Preferred Stock and (ii) warrants to purchase 27.5 million shares of common stock at an exercise price equal to $0.78, which the Company refers to as the Lender Warrants. Each share of Series 1 Non-Voting Convertible Preferred Stock has a par value of $0.0001 per share and a stated value equal to $1.00. The Series 1 Non-Voting Convertible Preferred Stock ranks (i) senior to the common stock and any other class or series of the Company's capital stock thereafter created, the terms of which specifically provide that such class or series shall rank junior to the Series 1 Non-Voting Convertible Preferred Stock, and (ii) pari passu with any class or series of our capital stock created specifically ranking, by its terms, on par with the Series 1 Non-Voting Convertible Preferred Stock. The Series 1 Non-Voting Convertible Preferred Stock shall be convertible into 27.5 million shares of common stock, determined by dividing the stated value per share of Series 1 Non-Voting Convertible Preferred Stock by the per share conversion price (as adjusted from time to time) and the Lender Warrants shall be exercisable, commencing upon receipt of any required stockholder approvals, and shall in all cases be subject to a 4.99% beneficial ownership limitation. The Company also entered into a side letter agreement, which provides for, among other things, the right of certain lenders to designate one director to the Company's board of directors and following, and subject to, approval by the Company's stockholders under the Nasdaq Stock Market, or Nasdaq, listing rules or confirmation by Nasdaq, that such appointments do not violate its rules, the lenders shall have the right to designate up to three additional directors to the Company's board of directors.

As of September 30, 2026, and December 31, 2025, the outstanding principal balance on the Term Loan was $108.9 million and $114.4 million respectively. The decrease reflects the application of the APP Sale proceeds on July 31, 2026.

Revolving Credit Facility

On March 29, 2021, we and certain of our subsidiaries entered into the Revolving Credit Agreement with JPMorgan, as administrative agent, issuing bank and swingline lender for a Revolving Credit Facility up to $50 million which was subsequently amended several times to, among other things, modify the maximum aggregate borrowing limit, transition the interest rate benchmark from LIBOR to SOFR, and extend the maturity date. We use the terms Revolving Credit Agreement and Revolving Credit Facility interchangeably.

As of December 31, 2025, we had zero borrowed under the Revolving Credit Facility. On February 17, 2026, we entered into the Termination Agreement to terminate the Revolving Credit Agreement. Pursuant to the terms of the Termination Agreement, the parties agreed to terminate the Revolving Credit Agreement subject to the survival of each of the provisions of the Revolving Credit Agreement and Loan Documents (as defined in the Revolving Credit Agreement) and in the certificates delivered in connection with or pursuant to the Revolving Credit Agreement that survive termination of the Revolving Credit Agreement.

The aforementioned financing arrangements and other transactions are more fully described in the notes to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Cash and Cash Equivalents

The cash, cash equivalents and restricted cash balances of $3.9 million and $6.3 million at September 30, 2026, and December 31, 2025, respectively, included $0.8 million and $2.9 million, respectively, held by foreign subsidiaries.

Material Cash Requirements

Our estimated material cash requirements include (i) finance lease payments, and (ii) operating lease payments, as well as other purchase obligations to support our operations. The Term Loan was satisfied in full on October 27, 2026, as further described in Item 1. Financial Statements, Note 17 - Subsequent Events. Refer to Item 1. Financial Statements, Note 11 - Debt, Note 8 - Leases, and Note 15 - Commitments and Contingencies for details relating to our material cash requirements for debt, our leasing arrangements, including future maturities of our operating lease liabilities, and purchase obligations, respectively. From time to time in the normal course of business, we will enter into agreements with suppliers which provide favorable pricing in return for a commitment to purchase minimum amounts of inventory over a defined time period.

Critical Accounting Policies and Estimates

The preceding discussion and analysis of our consolidated results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q. Our critical accounting policies and estimates are identified in Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II of the 2025 Annual Report and include the discussion of estimates used in indefinite lived intangible assets, long-lived tangible and finite-lived intangible assets, and inventory valuation. Such accounting policies and estimates require significant judgments and assumptions to be used in the preparation of the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and actual results could differ materially from the amounts reported.

Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, refer to Item 1. Financial Statements, Note 3 - Basis of Presentation and Significant Accounting Policies - Recent accounting pronouncements, to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Hydrofarm Holdings Group Inc. published this content on November 16, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 16, 2026 at 21:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]